The enzyme Na + , K + -ATPase is an integral membrane protein which transports sodium and potassium cations against an electrochemical gradient. The transport of Na + and K + ions is connected to an oscillation of the enzyme between the two conformational states, the E 1 (Na + ) and the E 2 (K + ) conformations. The enzymatic activity of ATPase is largley affected by different ligands complexation. This review reports the effects of several drugs such as AZT (anti-AIDS), cis-Pt (antitumor), aspirin (anti-inflammatory) and vitamin C (antioxidant) on the stability and secondary structure of Na,K-ATPase in vitro. Drugenzyme binding is mainly through H-bonding to the polypeptide C=O and C-N groups with two binding constants K 1(AZT) = 5.30 × 10 5 M -1 and K 2(AZT) = 9.80 × 10 3 M -1 for AZT and one binding constant for K cis-Pt = 1.93 × 10 4 M -1 , K aspirin = 6.45 × 10 3 M -1 and K ascorbate = 1.04 × 10 4 M -1 for cis-Pt, aspirin and ascorbic acid. The enzyme secondary structure was altered from that of α-helix 19.8% (free protein) to almost 22-26% and the β-sheet from 25.6% to 18-22%, upon drug complexation with the order of induced stability AZT > cis-Pt > ascorbate > aspirin.